UK Tribunal Overturns £89M Epilepsy Drug Pricing Fine
By Matthew Perlman ( June 7, 2018, 7:00 PM EDT) -- A U.K. appeals tribunal on Thursday sent a case accusing Pfizer and Flynn Pharma of charging the National Health Service excessive and unfair prices for an anti-epilepsy drug back to the country's competition authority after finding the watchdog had not properly shown that the companies abused their dominance....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.